233 related articles for article (PubMed ID: 19318668)
21. Addition of chemotherapy improves overall survival in patients with T2N0M0 non-small cell lung cancer undergoing definitive radiation therapy: An analysis of the SEER database.
Komiya T; Chaaya G; Powell E
Radiother Oncol; 2019 Feb; 131():75-80. PubMed ID: 30773190
[TBL] [Abstract][Full Text] [Related]
22. Satellite pulmonary nodule in the same lobe (T4N0) should not be staged as IIIB non-small cell lung cancer.
Bryant AS; Pereira SJ; Miller DL; Cerfolio RJ
Ann Thorac Surg; 2006 Nov; 82(5):1808-13; discussion 1813-4. PubMed ID: 17062253
[TBL] [Abstract][Full Text] [Related]
23. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer.
Carbone E; Asamura H; Takei H; Kondo H; Suzuki K; Miyaoka E; Tsuchiya R; Motta G
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):907-12. PubMed ID: 11689795
[TBL] [Abstract][Full Text] [Related]
24. [The new TNM classification in lung cancer].
Wrona A; Jassem J
Pneumonol Alergol Pol; 2010; 78(6):407-17. PubMed ID: 21077033
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.
He YY; Zhang XC; Yang JJ; Niu FY; Zeng Z; Yan HH; Xu CR; Guan JL; Zhong WZ; Yang LL; Guo LH; Wu YL
Clin Lung Cancer; 2014 Nov; 15(6):441-7. PubMed ID: 25044104
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of pleural effusion in patients with non-small cell lung cancer.
Sugiura S; Ando Y; Minami H; Ando M; Sakai S; Shimokata K
Clin Cancer Res; 1997 Jan; 3(1):47-50. PubMed ID: 9815536
[TBL] [Abstract][Full Text] [Related]
27. The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer.
Postmus PE; Brambilla E; Chansky K; Crowley J; Goldstraw P; Patz EF; Yokomise H; ; ; ;
J Thorac Oncol; 2007 Aug; 2(8):686-93. PubMed ID: 17762334
[TBL] [Abstract][Full Text] [Related]
28. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition.
Sculier JP; Chansky K; Crowley JJ; Van Meerbeeck J; Goldstraw P;
J Thorac Oncol; 2008 May; 3(5):457-66. PubMed ID: 18448996
[TBL] [Abstract][Full Text] [Related]
29. Results of T4 surgical cases in the Japanese Lung Cancer Registry Study: should mediastinal fat tissue invasion really be included in the T4 category?
Watanabe S; Asamura H; Miyaoka E; Okumura M; Yoshino I; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Yokoi K;
J Thorac Oncol; 2013 Jun; 8(6):759-65. PubMed ID: 23608818
[TBL] [Abstract][Full Text] [Related]
30. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.
Chansky K; Sculier JP; Crowley JJ; Giroux D; Van Meerbeeck J; Goldstraw P;
J Thorac Oncol; 2009 Jul; 4(7):792-801. PubMed ID: 19458556
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis.
Okada M; Tsubota N; Yoshimura M; Miyamoto Y; Nakai R
Ann Thorac Surg; 1999 Aug; 68(2):326-30; discussion 331. PubMed ID: 10475390
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of non-small cell lung cancer 3 cm or less in diameter.
Tateishi M; Fukuyama Y; Hamatake M; Kohdono S; Mitsudomi T; Ishida T; Sugimachi K
J Surg Oncol; 1995 Aug; 59(4):251-4. PubMed ID: 7630173
[TBL] [Abstract][Full Text] [Related]
33. IIIB-T4 non-small cell lung cancer: indications and results of surgical treatment.
Lucchi M; Viti A; Melfi F; Ambrogi M; Givigliano F; Dini P; Mussi A
J Cardiovasc Surg (Torino); 2007 Jun; 48(3):369-74. PubMed ID: 17505443
[TBL] [Abstract][Full Text] [Related]
34. The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system.
Oliaro A; Filosso PL; Cavallo A; Giobbe R; Mossetti C; Lyberis P; Cristofori RC; Ruffini E
Eur J Cardiothorac Surg; 2008 Aug; 34(2):438-43; discussion 443. PubMed ID: 18502660
[TBL] [Abstract][Full Text] [Related]
35. The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer.
Travis WD; Giroux DJ; Chansky K; Crowley J; Asamura H; Brambilla E; Jett J; Kennedy C; Rami-Porta R; Rusch VW; Goldstraw P;
J Thorac Oncol; 2008 Nov; 3(11):1213-23. PubMed ID: 18978555
[TBL] [Abstract][Full Text] [Related]
36. The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.
Fernandes AT; Mitra N; Xanthopoulos E; Evans T; Stevenson J; Langer C; Kucharczuk JC; Lin L; Rengan R
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):340-7. PubMed ID: 22104359
[TBL] [Abstract][Full Text] [Related]
37. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer.
Shepherd FA; Crowley J; Van Houtte P; Postmus PE; Carney D; Chansky K; Shaikh Z; Goldstraw P;
J Thorac Oncol; 2007 Dec; 2(12):1067-77. PubMed ID: 18090577
[TBL] [Abstract][Full Text] [Related]
38. The revised staging system for malignant pleural mesothelioma based on surveillance, epidemiology, and end results database.
Wang S; Ma K; Wang Q; Sun F; Shi Y; Zhan C; Jiang W
Int J Surg; 2017 Dec; 48():92-98. PubMed ID: 29050965
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification.
Maeda R; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
Chest; 2011 Dec; 140(6):1494-1502. PubMed ID: 21622548
[TBL] [Abstract][Full Text] [Related]
40. [Survival and prognostic factors in resected satellite-nodule T4 non-small cell lung cancer].
Ma K; Wang TY; He BL; Chang D; Hu XD; Yin ZY; Jiang H; Cui Y; Gao Z; Gong M
Zhonghua Wai Ke Za Zhi; 2009 Jan; 47(2):120-2. PubMed ID: 19563007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
